Clinical Trials Browser

Phase 1/2 × spartalizumab × Sarcoma × Clear all

Diabetes Mellitus, Insulin-Dependent, 12, Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Colonic Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT03609424 2023-01-03

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

Phase 1/2 Completed

39 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Clinical Trials

IT-01

PDR001 Plus Imatinib for Metastatic or Unresectable GIST